Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

645
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
645
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

712
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
712
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

3.3K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.3K
Pneumonia IV: Management01:28

Pneumonia IV: Management

675
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
675
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

2.4K
The pathophysiology of pneumonia involves the following steps:
2.4K
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

1.8K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The multifaceted role of mast cells in joint inflammation and arthritis.

Osteoarthritis and cartilage·2023
Same author

[Eosinophilia in pulmonary infections].

Der Pneumologe·2020
Same author

Study of dijet events with a large rapidity gap between the two leading jets in pp collisions at <math> </math> <math></math>.

The European physical journal. C, Particles and fields·2019
Same author

Search for standard model production of four top quarks with same-sign and multilepton final states in proton-proton collisions at <math> </math>.

The European physical journal. C, Particles and fields·2019
Same author

Combined measurements of Higgs boson couplings in proton-proton collisions at <math> </math>.

The European physical journal. C, Particles and fields·2019
Same author

Search for vector-like quarks in events with two oppositely charged leptons and jets in proton-proton collisions at <math> </math>.

The European physical journal. C, Particles and fields·2019
Same journal

[Outpatient pulmonary rehabilitation].

Der Pneumologe·2022
Same journal

[Parapneumonic pleural effusion in a 37-year-old female patient?]

Der Pneumologe·2022
Same journal

[Development and progress].

Der Pneumologe·2022
Same journal

[Development and progress in mechanical ventilation].

Der Pneumologe·2022
Same journal

[Development and progress in respiratory tract infections].

Der Pneumologe·2022
Same journal

[Benefits and risks of treatment with oxygen].

Der Pneumologe·2022
See all related articles

Related Experiment Video

Updated: Dec 25, 2025

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.5K

[Pneumonia in immunocompromised patients].

A Moeser1, C Lange2, M von Lilienfeld-Toal3

  • 11Zentrum für Infektionsmedizin und Krankenhaushygiene, Universitätsklinikum Jena, Am Klinikum 1, 07747 Jena, Deutschland.

Der Pneumologe
|March 28, 2020
PubMed
Summary
This summary is machine-generated.

Pneumonia in immunocompromised patients presents unique challenges due to diverse pathogens. Advanced imaging and diagnostic tests aid in identifying the specific cause for better treatment outcomes.

Keywords:
BronchoscopyImmunodeficiencyImmunosuppressionInfectious diseasesOpportunistic infections

More Related Videos

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

15.1K
A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

3.0K

Related Experiment Videos

Last Updated: Dec 25, 2025

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.5K
A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

15.1K
A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

3.0K

Area of Science:

  • Medical Science
  • Infectious Diseases
  • Immunology

Context:

  • Pneumonia frequently affects immunocompromised individuals, often leading to complex disease courses.
  • Pathogen types in these patients correlate with the specific immunosuppression cause, ranging from congenital to acquired.
  • Conditions like COPD and advanced age share similarities with immunosuppression, impacting pneumonia presentation.

Purpose:

  • To explore the diverse range of pathogens causing pneumonia in immunocompromised patients.
  • To highlight the diagnostic superiority of computed tomography over chest x-ray.
  • To outline various non-invasive and invasive diagnostic methods for pathogen identification.

Summary:

  • Immunocompromised patients experience frequent and complicated pneumonia, with pathogens linked to the type of immunosuppression.
  • Computed tomography offers better pathogen indication than chest x-ray.
  • Diagnostic tools include non-invasive blood cultures, antigen, and PCR tests, complemented by invasive fiberoptic bronchoscopy.

Impact:

  • Improved understanding of pneumonia in immunocompromised populations.
  • Enhanced diagnostic strategies for timely and accurate pathogen identification.
  • Potential for more targeted and effective treatment regimens in vulnerable patient groups.